Highland Capital Management (Tennessee)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,538
Closed -$831K 418
2025
Q4
$831K Buy
+2,538
New +$805K 0.04% 246
2024
Q4
Sell
-3,924
Closed -$1.26M 378
2024
Q3
$1.26M Sell
3,924
-2,478
-39% -$811K 0.07% 214
2024
Q2
$2M Sell
6,402
-1,215
-16% -$357K 0.12% 162
2024
Q1
$2.17M Buy
7,617
+9
+0.1% +$2.63K 0.12% 169
2023
Q4
$2.19M Sell
7,608
-24
-0.3% -$6.54K 0.14% 167
2023
Q3
$2.05M Sell
7,632
-140
-2% -$34.9K 0.14% 167
2023
Q2
$1.73M Sell
7,772
-27
-0.3% -$6.26K 0.11% 180
2023
Q1
$1.89M Sell
7,799
-1,183
-13% -$290K 0.14% 147
2022
Q4
$2.36M Buy
8,982
+962
+12% +$258K 0.17% 151
2022
Q3
$1.81M Sell
8,020
-104
-1% -$25.2K 0.14% 158
2022
Q2
$1.98M Buy
8,124
+5
+0.1% +$1.23K 0.14% 164
2022
Q1
$1.96M Buy
8,119
+32
+0.4% +$7.35K 0.12% 178
2021
Q4
$1.82M Sell
8,087
-100
-1% -$21.1K 0.1% 198
2021
Q3
$1.74M Sell
8,187
-712
-8% -$164K 0.11% 203
2021
Q2
$2.17M Sell
8,899
-354
-4% -$87.1K 0.13% 171
2021
Q1
$2.3M Sell
9,253
-715
-7% -$171K 0.14% 164
2020
Q4
$2.29M Sell
9,968
-19,472
-66% -$4.49M 0.15% 164
2020
Q3
$7.48M Sell
29,440
-837
-3% -$207K 0.53% 51
2020
Q2
$7.14M Buy
30,277
+3,151
+12% +$719K 0.56% 46
2020
Q1
$5.5M Buy
27,126
+6,343
+31% +$1.39M 0.52% 55
2019
Q4
$5.01M Sell
20,783
-12,383
-37% -$2.73M 0.35% 81
2019
Q3
$6.42M Sell
33,166
-11,861
-26% -$2.28M 0.48% 59
2019
Q2
$8.3M Buy
45,027
+12,731
+39% +$2.28M 0.62% 42
2019
Q1
$6.14M Sell
32,296
-622
-2% -$119K 0.47% 61
2018
Q4
$6.41M Sell
32,918
-3,025
-8% -$590K 0.54% 48
2018
Q3
$7.45M Buy
35,943
+8,486
+31% +$1.67M 0.54% 49
2018
Q2
$5.07M Buy
27,457
+262
+1% +$46.3K 0.39% 73
2018
Q1
$4.64M Buy
27,195
+131
+0.5% +$24K 0.36% 83
2017
Q4
$4.71M Sell
27,064
-494
-2% -$87.4K 0.36% 91
2017
Q3
$5.14M Sell
27,558
-6,333
-19% -$1.12M 0.41% 80
2017
Q2
$5.84M Buy
33,891
+22,465
+197% +$3.65M 0.47% 66
2017
Q1
$1.88M Sell
11,426
-2,331
-17% -$387K 0.15% 142
2016
Q4
$2.01M Sell
13,757
-4,051
-23% -$610K 0.17% 141
2016
Q3
$2.97M Buy
17,808
+80
+0.5% +$13.5K 0.25% 114
2016
Q2
$2.7M Sell
17,728
-10
-0.1% -$1.55K 0.23% 117
2016
Q1
$2.66M Buy
17,738
+367
+2% +$54.5K 0.23% 124
2015
Q4
$2.82M Buy
17,371
+11,610
+202% +$1.82M 0.23% 130
2015
Q3
$797K Buy
5,761
+4,273
+287% +$674K 0.07% 252
2015
Q2
$228K Hold
1,488
0.02% 308
2015
Q1
$238K Buy
1,488
+175
+13% +$27.6K 0.05% 133
2014
Q4
$209K Buy
+1,313
New +$205K 0.04% 155

Other funds holding AMGN

Highland Capital Management (Tennessee)'s AMGN Position: Q1 2026 in Review

Highland Capital Management (Tennessee) sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2,538 shares — an estimated $831K sold.

Highland Capital Management (Tennessee) first reported a position in AMGN in Q4 2014 and held it in 41 quarters. The position peaked at $8.3M in Q2 2019. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Highland Capital Management (Tennessee) reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 2,538 Amgen shares in Q1 2026, an estimated $831K.
  • Highland Capital Management (Tennessee) first reported a position in Amgen in Q4 2014 and held it in 41 quarters.
  • Highland Capital Management (Tennessee)'s Amgen position peaked at $8.3M in Q2 2019.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2026, filed 13 Apr 2026.